v3.26.1
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Company’s consolidated balance sheets that sum to the total of the amounts shown in the consolidated statement of cash flows as of March 31, 2026 and March 31, 2025 (in thousands):

March 31,
20262025
Cash and cash equivalents$62,431 $105,156 
Restricted cash (included within Other non-current assets)654 654 
    Total
$63,085 $105,810 
Schedule of Restrictions on Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Company’s consolidated balance sheets that sum to the total of the amounts shown in the consolidated statement of cash flows as of March 31, 2026 and March 31, 2025 (in thousands):

March 31,
20262025
Cash and cash equivalents$62,431 $105,156 
Restricted cash (included within Other non-current assets)654 654 
    Total
$63,085 $105,810 
Schedule of Antidilutive Securities Excluded from Computation of Diluted Weighted-Average Ordinary Shares Outstanding
The following potentially dilutive securities have been excluded from the computation of diluted weighted-average ordinary shares outstanding for the three months ended March 31, 2026 and March 31, 2025, as they would be anti-dilutive:

Three Months Ended
March 31, 2026		Three Months Ended
March 31, 2025
Restricted stock awards— 34,746 
Restricted stock units1,154,321 1,125,346 
Stock options15,428,753 20,300,306 
16,583,074 21,460,398